Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Peginterferon Ξ±-2b plus an anti-PD-1
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial -
Radiotherapy combined with TKI and Anti-PD-1 Antibody
Jian Li
Stage IIIA Hepatocellular Carcinoma
1 trial -
anti-CD19/BCMA-UCAR-T cells
The First People's Hospital of Lianyungang
Rheumatoid Arthritis
1 trial -
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial -
anti-Thyroid Drugs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Graves Disease
1 trial -
anti-thymocyte globulin
United Therapeutics Europe Ltd
Leukemia
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Neutropenia
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Purpura, Schoenlein-Henoch
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Graft Versus Host Disease
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Immunologic Deficiency Syndromes
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Chediak-Higashi Syndrome
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Anti-Inflammatory Agents, Non-Steroidal
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources